iRhythm Holdings, Inc.
As of Oct 22, 2026, iRhythm Holdings is in Stage 4, the downtrend phase, now in week 4 (since Sep 28, 2026). It closed at $119.64, 36.8% below its 52-week high and below its 200-day average, which is falling.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagn… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is IRTC early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
IRTC among Medical Devices74th of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …74 | IRTC | Stage 4 · wk 4 | 32 | +7.1% |
iRhythm Holdings: quick answers
What stage is iRhythm Holdings in?
As of Oct 22, 2026, iRhythm Holdings (IRTC) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 28, 2026 and is in week 4. What the four stages mean
Is iRhythm Holdings in an uptrend?
No. iRhythm Holdings is in a Stage 4 downtrend. It trades 3.4% below its 200-day average, which is falling.
How far is iRhythm Holdings from its 52-week high?
iRhythm Holdings closed at $119.64 on Oct 22, 2026, 36.8% below its 52-week high of $189.25. Its 52-week low is $101.79.
How has iRhythm Holdings performed over the past year?
As of Oct 22, 2026, iRhythm Holdings is down 32.9% over the past year and down 31.7% so far in 2026.
Which sector and industry is iRhythm Holdings in?
iRhythm Holdings is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.